Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results

Core Insights - Twist Bioscience Corporation announced its financial results for the fourth quarter and full year of fiscal 2025, ending September 30, 2025 [1] Financial Results - The company will issue its financial results before the market opens on November 14, 2025, and will hold a conference call at 8:00 a.m. Eastern Time to discuss these results [10] Business Highlights - Twist Bioscience focuses on providing synthetic DNA tools for various fields including medicine, agriculture, industrial chemicals, and defense, aiming to improve lives and sustainability [4] - The company utilizes an innovative silicon-based DNA Synthesis Platform that offers precision and efficiency in synthesis, sequencing, and therapeutics discovery [5] Upcoming Events - Emily M. Leproust, Ph.D., CEO, and Adam Laponis, CFO, will participate in a fireside chat at the 7th Annual Wolfe Research Healthcare Conference on November 17, 2025 [8]